RedHill Biopharma Ltd (RDHL)

[Amatuer17]

NR - I hv read your posts so value your opinion.

Why you consider this to be more risky that other biotech?

The company has enormous pipeline and multiple p2 and p3 trials (not many small biotechs can boast that)

They are executing very well - meeting most of the milestones as declared

They have 70 million cash in hand for a market cap of $160 million - which is huge from just cash position and ability to run multiple trials

They have good mgmt team(not one or 2 people running the co) and o/h are reasonable - not huge.

They have one drug in cancer space and 2 drug that could add small revenue.

What I am missing? Any clues?

I really like this investment and thing it can be a BO target in 2-3 years and can give us 4-5 bagger from here.

I draw parallel between this and LGND (after 4 years - it has gone from 13 to 100+)